THE USE OF HUMAN BLOOD DERIVATIVES IN A POPULATION WHERE SUCH PRODUCTS ARE READILY AVAILABLE IN ADEQUATE QUANTITY WITHOUT COST.
D001771:Blood Banks; D002570:Ceruloplasmin; D003029:Coagulants; D003850:Deoxyribonuclease I; D005169:Factor VIII; D005340:Fibrinogen; D005341:Fibrinolysin; D006801:Humans; D008824:Michigan; D010949:Plasma; D012709:Serum Albumin; D013223:Statistics as Topic; D013299:Streptodornase and Streptokinase; D013300:Streptokinase; D014168:Transferrin; D005719:gamma-Globulins
D003029:Coagulants; D012709:Serum Albumin; D014168:Transferrin; D005719:gamma-Globulins; C427184:recombinant factor VIII SQ; D005169:Factor VIII; D005340:Fibrinogen; D002570:Ceruloplasmin; D013299:Streptodornase and Streptokinase; D003850:Deoxyribonuclease I; D013300:Streptokinase; D005341:Fibrinolysin
BLOOD BANKS; CERULOPLASMIN; FACTOR VIII; FIBRINOGEN; FIBRINOLYSIN; GAMMA GLOBULIN; MICHIGAN; PLASMA; SERUM ALBUMIN; STATISTICS; STREPTODORNASE AND STREPTOKINASE; TRANSFERRIN